Summary

The drug abuse testing market was valued at $5.0 million in 2023, and is projected to reach $8.8 million by 2033, growing at a CAGR of 6% from 2024 to 2033.
Drug abuse testing refers to the scientific process of identifying the presence of illicit drugs, prescription medications, or their metabolites in a person's system. This testing is conducted using biological specimens such as urine, blood, saliva, hair, or sweat to determine if an individual has used specific substances. Drug abuse testing is a critical tool in workplace safety, clinical diagnostics, legal investigations, and rehabilitation programs.
Alarming increase in prevalence of substance abuse disorders worldwide is a primary driver of the drug abuse testing market. According to a report by the United Nations Office on Drugs and Crime (UNODC), over 284 million people aged 15–64 used drugs at least once in 2022, underscoring the need for widespread testing. In addition, rise in awareness about the impact of substance abuse on public safety, such as impaired driving and drug-related crimes, has driven the demand for routine drug testing in law enforcement and traffic monitoring programs. Moreover, increase in global drug availability significantly contributes toward the market growth. For instance, the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) reported in 2024 that Europe is experiencing unprecedented availability of various drugs, with cannabis being the most commonly used illicit drug, followed by cocaine. Furthermore, the availability of cost-effective and easy-to-use home drug testing kits has seen increased adoption among individuals and families, contributing to market expansion. However, sophisticated drug testing techniques, such as liquid chromatography-mass spectrometry, are expensive. This can limit their adoption, especially in resource-constrained healthcare settings. Fear of societal judgment and discrimination may deter individuals from undergoing drug testing voluntarily, further affecting the growth of testing programs. On the contrary, technological innovations, such as point-of-care testing devices, improved immunoassays, and mass spectrometry techniques, have made drug testing more accurate, faster, and accessible. Such developments are expected to offer remunerative opportunities for the expansion of the global market during the forecast period.
The drug abuse testing market is segmented into product & service, sample type, end user, and region. By product & service, the market is divided into analyzers, rapid testing devices, consumables and laboratory services. The analyzers segment is further segmented into immunoassay analyzers, chromatography analyzers and breath analyzers. The rapid testing devices is subdivided into urine testing devices and oral fluid testing devices. The consumables segment is further categorized into assay kits, sample collection cups, calibrators & controls, and others. Depending on sample type, the market is segregated into urine, oral fluid, breath, hair, and other samples. By end user, it is fragmented into workplaces & schools, criminal justice systems & law enforcement agencies, research laboratories, and hospitals. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Key Findings
By product & service, the analyzers segment dominated the market share in 2023.
On the basis of sample type, the urine segment exhibit the highest growth in 2023.
Depending on end user segment, the workplaces & schools segment garnered the largest share in 2023.
Region wise, North America held the largest market share in 2023, and is projected to grow at a high pace during the forecast period.
 
Competition Analysis
Competitive analysis and profiles of the major players in the global drug abuse testing market include The Drägerwerk AG & Co. KGaA, Abbott Laboratories, F. HOFFMANN-LA ROCHE AG, Bio Rad Laboratories, Inc., Siemens AG, Thermo Fisher Scientific, Inc., Laboratory Corporation of America Holdings, Danaher Corporation, Quest Diagnostics Incorporated, and Express Diagnostics International Inc. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships to sustain the intense competition and gain a strong foothold in the global market.
 

Additional benefits you will get with this purchase are:
● Quarterly Update and* (only available with a corporate license, on listed price)
● 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
● Free Upcoming Version on the Purchase of Five and Enterprise User License.
● 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
● 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
● Free data Pack on the Five and Enterprise User License. (Excel version of the report)
● Free Updated report if the report is 6-12 months old or older.
● 24-hour priority response*
● Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)
● Regulatory Guidelines
● Additional company profiles with specific to client's interest
● Additional country or region analysis- market size and forecast
● Average Selling Price Analysis / Price Point Analysis
● Criss-cross segment analysis- market size and forecast
● Expanded list for Company Profiles
● Historic market data
● Key player details (including location, contact details, supplier/vendor network etc. in excel format)
Key Market Segments
By Product And Service
● Analyzers
○ Immunoassay analyzers
○ Chromatography analyzers
○ Breath analyzers
● Rapid Testing Devices
○ Urine testing devices
○ Oral fluid testing devices
● Consumables
○ Assay kits
○ Sample collection cups
○ Calibrators and controls
○ Others
● Laboratory Services
By Sample Type
● Urine
● Oral Fluid
● Breath
● Hair
● Other Samples
By End User
● Workplaces and Schools
● Criminal Justice Systems and Law Enforcement Agencies
● Research laboratories
● Hospitals
By Region
● North America
○ U.S.
○ Canada
○ Mexico
● Europe
○ France
○ Germany
○ Italy
○ Spain
○ UK
○ Rest of Europe
● Asia-Pacific
○ China
○ Japan
○ India
○ South Korea
○ Australia
○ Rest of Asia-Pacific
● LAMEA
○ Brazil
○ South Africa
○ Saudi Arabia
○ Rest of LAMEA
● Key Market Players
○ The Drägerwerk AG & Co. KGaA
○ Abbott Laboratories
○ F. HOFFMANN-LA ROCHE AG
○ Bio Rad Laboratories, Inc.
○ Siemens AG
○ Thermo Fisher Scientific, Inc.
○ Laboratory Corporation of America Holdings
○ Danaher Corporation
○ Quest Diagnostics Incorporated
○ Express Diagnostics International Inc.

ページTOPに戻る

Table of Contents

CHAPTER 1: INTRODUCTION
1.1. Report Description
1.2. Key Market Segments
1.3. Key Benefits
1.4. Research Methodology
1.4.1. Primary Research
1.4.2. Secondary Research
1.4.3. Analyst Tools and Models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET LANDSCAPE
3.1. Market Definition and Scope
3.2. Key Findings
3.2.1. Top Investment Pockets
3.2.2. Top Winning Strategies
3.3. Porter's Five Forces Analysis
3.3.1. Bargaining Power of Suppliers
3.3.2. Threat of New Entrants
3.3.3. Threat of Substitutes
3.3.4. Competitive Rivalry
3.3.5. Bargaining Power among Buyers
3.4. Market Dynamics
3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities
CHAPTER 4: DRUG ABUSE TESTING MARKET, BY PRODUCT AND SERVICE
4.1. Market Overview
4.1.1 Market Size and Forecast, By Product And Service
4.2. Analyzers
4.2.1. Key Market Trends, Growth Factors and Opportunities
4.2.2. Market Size and Forecast, By Region
4.2.3. Market Share Analysis, By Country
4.2.5. Immunoassay analyzers
4.2.5.1. Market Size and Forecast
4.2.6. Chromatography analyzers
4.2.6.1. Market Size and Forecast
4.2.7. Breath analyzers
4.2.7.1. Market Size and Forecast
4.3. Rapid Testing Devices
4.3.1. Key Market Trends, Growth Factors and Opportunities
4.3.2. Market Size and Forecast, By Region
4.3.3. Market Share Analysis, By Country
4.3.5. Urine testing devices
4.3.5.1. Market Size and Forecast
4.3.6. Oral fluid testing devices
4.3.6.1. Market Size and Forecast
4.4. Consumables
4.4.1. Key Market Trends, Growth Factors and Opportunities
4.4.2. Market Size and Forecast, By Region
4.4.3. Market Share Analysis, By Country
4.4.5. Assay kits
4.4.5.1. Market Size and Forecast
4.4.6. Sample collection cups
4.4.6.1. Market Size and Forecast
4.4.7. Calibrators and controls
4.4.7.1. Market Size and Forecast
4.4.8. Others
4.4.8.1. Market Size and Forecast
4.5. Laboratory Services
4.5.1. Key Market Trends, Growth Factors and Opportunities
4.5.2. Market Size and Forecast, By Region
4.5.3. Market Share Analysis, By Country
CHAPTER 5: DRUG ABUSE TESTING MARKET, BY SAMPLE TYPE
5.1. Market Overview
5.1.1 Market Size and Forecast, By Sample Type
5.2. Urine
5.2.1. Key Market Trends, Growth Factors and Opportunities
5.2.2. Market Size and Forecast, By Region
5.2.3. Market Share Analysis, By Country
5.3. Oral Fluid
5.3.1. Key Market Trends, Growth Factors and Opportunities
5.3.2. Market Size and Forecast, By Region
5.3.3. Market Share Analysis, By Country
5.4. Breath
5.4.1. Key Market Trends, Growth Factors and Opportunities
5.4.2. Market Size and Forecast, By Region
5.4.3. Market Share Analysis, By Country
5.5. Hair
5.5.1. Key Market Trends, Growth Factors and Opportunities
5.5.2. Market Size and Forecast, By Region
5.5.3. Market Share Analysis, By Country
5.6. Other Samples
5.6.1. Key Market Trends, Growth Factors and Opportunities
5.6.2. Market Size and Forecast, By Region
5.6.3. Market Share Analysis, By Country
CHAPTER 6: DRUG ABUSE TESTING MARKET, BY END USER
6.1. Market Overview
6.1.1 Market Size and Forecast, By End User
6.2. Workplaces And Schools
6.2.1. Key Market Trends, Growth Factors and Opportunities
6.2.2. Market Size and Forecast, By Region
6.2.3. Market Share Analysis, By Country
6.3. Criminal Justice Systems And Law Enforcement Agencies
6.3.1. Key Market Trends, Growth Factors and Opportunities
6.3.2. Market Size and Forecast, By Region
6.3.3. Market Share Analysis, By Country
6.4. Research Laboratories
6.4.1. Key Market Trends, Growth Factors and Opportunities
6.4.2. Market Size and Forecast, By Region
6.4.3. Market Share Analysis, By Country
6.5. Hospitals
6.5.1. Key Market Trends, Growth Factors and Opportunities
6.5.2. Market Size and Forecast, By Region
6.5.3. Market Share Analysis, By Country
CHAPTER 7: DRUG ABUSE TESTING MARKET, BY REGION
7.1. Market Overview
7.1.1 Market Size and Forecast, By Region
7.2. North America
7.2.1. Key Market Trends and Opportunities
7.2.2. Market Size and Forecast, By Product And Service
7.2.3. Market Size and Forecast, By Sample Type
7.2.4. Market Size and Forecast, By End User
7.2.5. Market Size and Forecast, By Country
7.2.6. U.S. Drug Abuse Testing Market
7.2.6.1. Market Size and Forecast, By Product And Service
7.2.6.2. Market Size and Forecast, By Sample Type
7.2.6.3. Market Size and Forecast, By End User
7.2.7. Canada Drug Abuse Testing Market
7.2.7.1. Market Size and Forecast, By Product And Service
7.2.7.2. Market Size and Forecast, By Sample Type
7.2.7.3. Market Size and Forecast, By End User
7.2.8. Mexico Drug Abuse Testing Market
7.2.8.1. Market Size and Forecast, By Product And Service
7.2.8.2. Market Size and Forecast, By Sample Type
7.2.8.3. Market Size and Forecast, By End User
7.3. Europe
7.3.1. Key Market Trends and Opportunities
7.3.2. Market Size and Forecast, By Product And Service
7.3.3. Market Size and Forecast, By Sample Type
7.3.4. Market Size and Forecast, By End User
7.3.5. Market Size and Forecast, By Country
7.3.6. France Drug Abuse Testing Market
7.3.6.1. Market Size and Forecast, By Product And Service
7.3.6.2. Market Size and Forecast, By Sample Type
7.3.6.3. Market Size and Forecast, By End User
7.3.7. Germany Drug Abuse Testing Market
7.3.7.1. Market Size and Forecast, By Product And Service
7.3.7.2. Market Size and Forecast, By Sample Type
7.3.7.3. Market Size and Forecast, By End User
7.3.8. Italy Drug Abuse Testing Market
7.3.8.1. Market Size and Forecast, By Product And Service
7.3.8.2. Market Size and Forecast, By Sample Type
7.3.8.3. Market Size and Forecast, By End User
7.3.9. Spain Drug Abuse Testing Market
7.3.9.1. Market Size and Forecast, By Product And Service
7.3.9.2. Market Size and Forecast, By Sample Type
7.3.9.3. Market Size and Forecast, By End User
7.3.10. UK Drug Abuse Testing Market
7.3.10.1. Market Size and Forecast, By Product And Service
7.3.10.2. Market Size and Forecast, By Sample Type
7.3.10.3. Market Size and Forecast, By End User
7.3.11. Rest Of Europe Drug Abuse Testing Market
7.3.11.1. Market Size and Forecast, By Product And Service
7.3.11.2. Market Size and Forecast, By Sample Type
7.3.11.3. Market Size and Forecast, By End User
7.4. Asia-Pacific
7.4.1. Key Market Trends and Opportunities
7.4.2. Market Size and Forecast, By Product And Service
7.4.3. Market Size and Forecast, By Sample Type
7.4.4. Market Size and Forecast, By End User
7.4.5. Market Size and Forecast, By Country
7.4.6. China Drug Abuse Testing Market
7.4.6.1. Market Size and Forecast, By Product And Service
7.4.6.2. Market Size and Forecast, By Sample Type
7.4.6.3. Market Size and Forecast, By End User
7.4.7. Japan Drug Abuse Testing Market
7.4.7.1. Market Size and Forecast, By Product And Service
7.4.7.2. Market Size and Forecast, By Sample Type
7.4.7.3. Market Size and Forecast, By End User
7.4.8. India Drug Abuse Testing Market
7.4.8.1. Market Size and Forecast, By Product And Service
7.4.8.2. Market Size and Forecast, By Sample Type
7.4.8.3. Market Size and Forecast, By End User
7.4.9. South Korea Drug Abuse Testing Market
7.4.9.1. Market Size and Forecast, By Product And Service
7.4.9.2. Market Size and Forecast, By Sample Type
7.4.9.3. Market Size and Forecast, By End User
7.4.10. Australia Drug Abuse Testing Market
7.4.10.1. Market Size and Forecast, By Product And Service
7.4.10.2. Market Size and Forecast, By Sample Type
7.4.10.3. Market Size and Forecast, By End User
7.4.11. Rest of Asia-Pacific Drug Abuse Testing Market
7.4.11.1. Market Size and Forecast, By Product And Service
7.4.11.2. Market Size and Forecast, By Sample Type
7.4.11.3. Market Size and Forecast, By End User
7.5. LAMEA
7.5.1. Key Market Trends and Opportunities
7.5.2. Market Size and Forecast, By Product And Service
7.5.3. Market Size and Forecast, By Sample Type
7.5.4. Market Size and Forecast, By End User
7.5.5. Market Size and Forecast, By Country
7.5.6. Brazil Drug Abuse Testing Market
7.5.6.1. Market Size and Forecast, By Product And Service
7.5.6.2. Market Size and Forecast, By Sample Type
7.5.6.3. Market Size and Forecast, By End User
7.5.7. South Africa Drug Abuse Testing Market
7.5.7.1. Market Size and Forecast, By Product And Service
7.5.7.2. Market Size and Forecast, By Sample Type
7.5.7.3. Market Size and Forecast, By End User
7.5.8. Saudi Arabia Drug Abuse Testing Market
7.5.8.1. Market Size and Forecast, By Product And Service
7.5.8.2. Market Size and Forecast, By Sample Type
7.5.8.3. Market Size and Forecast, By End User
7.5.9. Rest of LAMEA Drug Abuse Testing Market
7.5.9.1. Market Size and Forecast, By Product And Service
7.5.9.2. Market Size and Forecast, By Sample Type
7.5.9.3. Market Size and Forecast, By End User
CHAPTER 8: COMPETITIVE LANDSCAPE
8.1. Introduction
8.2. Top Winning Strategies
8.3. Product Mapping Of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Top Player Positioning, 2023
CHAPTER 9: COMPANY PROFILES
9.1. The Drägerwerk AG And Co. KGaA
9.1.1. Company Overview
9.1.2. Key Executives
9.1.3. Company Snapshot
9.1.4. Operating Business Segments
9.1.5. Product Portfolio
9.1.6. Business Performance
9.1.7. Key Strategic Moves and Developments
9.2. Abbott Laboratories
9.2.1. Company Overview
9.2.2. Key Executives
9.2.3. Company Snapshot
9.2.4. Operating Business Segments
9.2.5. Product Portfolio
9.2.6. Business Performance
9.2.7. Key Strategic Moves and Developments
9.3. F. HOFFMANN-LA ROCHE AG
9.3.1. Company Overview
9.3.2. Key Executives
9.3.3. Company Snapshot
9.3.4. Operating Business Segments
9.3.5. Product Portfolio
9.3.6. Business Performance
9.3.7. Key Strategic Moves and Developments
9.4. Bio Rad Laboratories, Inc.
9.4.1. Company Overview
9.4.2. Key Executives
9.4.3. Company Snapshot
9.4.4. Operating Business Segments
9.4.5. Product Portfolio
9.4.6. Business Performance
9.4.7. Key Strategic Moves and Developments
9.5. Siemens AG
9.5.1. Company Overview
9.5.2. Key Executives
9.5.3. Company Snapshot
9.5.4. Operating Business Segments
9.5.5. Product Portfolio
9.5.6. Business Performance
9.5.7. Key Strategic Moves and Developments
9.6. Thermo Fisher Scientific, Inc.
9.6.1. Company Overview
9.6.2. Key Executives
9.6.3. Company Snapshot
9.6.4. Operating Business Segments
9.6.5. Product Portfolio
9.6.6. Business Performance
9.6.7. Key Strategic Moves and Developments
9.7. Laboratory Corporation Of America Holdings
9.7.1. Company Overview
9.7.2. Key Executives
9.7.3. Company Snapshot
9.7.4. Operating Business Segments
9.7.5. Product Portfolio
9.7.6. Business Performance
9.7.7. Key Strategic Moves and Developments
9.8. Danaher Corporation
9.8.1. Company Overview
9.8.2. Key Executives
9.8.3. Company Snapshot
9.8.4. Operating Business Segments
9.8.5. Product Portfolio
9.8.6. Business Performance
9.8.7. Key Strategic Moves and Developments
9.9. Quest Diagnostics Incorporated
9.9.1. Company Overview
9.9.2. Key Executives
9.9.3. Company Snapshot
9.9.4. Operating Business Segments
9.9.5. Product Portfolio
9.9.6. Business Performance
9.9.7. Key Strategic Moves and Developments
9.10. Express Diagnostics International Inc.
9.10.1. Company Overview
9.10.2. Key Executives
9.10.3. Company Snapshot
9.10.4. Operating Business Segments
9.10.5. Product Portfolio
9.10.6. Business Performance
9.10.7. Key Strategic Moves and Developments